The Pharmaceutical Distribution Security Alliance is a multi-stakeholder and interdisciplinary initiative. Membership spans the entire spectrum of the U.S. pharmaceutical distribution system, including manufacturers, wholesale distributors, third-party logistics providers, and pharmacies. More than 30 companies are formal members of PDSA, while many other external stakeholders provide additional policy and technical support.
PDSA played a critical role in helping develop and enact federal legislation (the Drug Supply Chain Security Act) which protects patient safety and ensures security of the drug supply chain, through a single national uniform system for serializing and tracing pharmaceuticals. PDSA now works with congressional policy makers and the federal Food and Drug Administration (FDA) to clarify and implement this new system and to address other related issues of importance to the pharmaceutical distribution supply chain.
Members of PDSA include leading brand and generic biologic and pharmaceutical manufacturers, primary and secondary wholesale distributors, pharmacies, and third-party logistics providers as well as leading trade associations representing the interest of these stakeholders.
PDSA leaders explain the recently enacted Drug Quality and Security Act and the process toward implementing a single, uniform and national pharmaceutical supply chain solution.
PDSA leaders review the Drug Quality and Security Act, offer a brief history of U.S. pharmaceutical distribution, and detail “next steps” toward a single, uniform and national pharmaceutical supply chain solution.